Brukinsa Interactions
There are 524 drugs known to interact with Brukinsa (zanubrutinib), along with 6 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 231 are major, 290 are moderate, and 3 are minor.
- View all 524 medications that may interact with Brukinsa
- View Brukinsa alcohol/food interactions (2)
- View Brukinsa disease interactions (6)
Most frequently checked interactions
View interaction reports for Brukinsa (zanubrutinib) and the medicines listed below.
- acyclovir
- albuterol
- allopurinol
- amlodipine
- amoxicillin
- atorvastatin
- biotin
- Eliquis (apixaban)
- famotidine
- finasteride
- folic acid
- furosemide
- gabapentin
- Jardiance (empagliflozin)
- levothyroxine
- lisinopril
- losartan
- magnesium oxide
- metformin
- metoprolol
- omeprazole
- pantoprazole
- prednisone
- rosuvastatin
- tamsulosin
- tramadol
- Tylenol (acetaminophen)
- valacyclovir
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Brukinsa alcohol/food interactions
There are 2 alcohol/food interactions with Brukinsa (zanubrutinib).
Brukinsa disease interactions
There are 6 disease interactions with Brukinsa (zanubrutinib) which include:
Report options
More about Brukinsa (zanubrutinib)
- Brukinsa consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (37)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Acalabrutinib
Acalabrutinib (Calquence) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Ibrutinib
Ibrutinib (Imbruvica) is a Bruton's tyrosine kinase inhibitor used for certain blood cancers and ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
